EPRX Eupraxia Pharmaceuticals Inc.
Company Analysis
Latest News
Eupraxia's Losses Nearly Double as It Bets Big on a Single Drug Trial — Can the Cash Last Long Enough to Prove It Works?
Shares of Eupraxia Pharmaceuticals plunged 11.9% to $5.90 on August 12 after second-quarter results revealed sharply escalating costs at this clinical-stage...
🔴 Eupraxia Pharmaceuticals is trading 11.9% down in pre-market after net loss widened to $14.5 million
Eupraxia Pharmaceuticals is trading 11.94% down at $5.90 after its August 11, 2026 second-quarter results showed a $14.5 million net loss, up from $8.7 million...
Eupraxia Pharmaceuticals' second quarter 2026 EPS beat estimates as liquidity reached $133.7M
Eupraxia Pharmaceuticals reported a net loss of $14.5 million for the second quarter of 2026, outperforming analyst expectations for the period. As a...
🔴 Eupraxia Pharmaceuticals is trading 5.17% down today in pre-market — No confirmed company-specific catalyst identified
Eupraxia Pharmaceuticals is trading 5.17% down at $6.42 in pre-market after declining from the August 7 close of $6.77; no confirmed company-specific...
🟢 Eupraxia Pharmaceuticals is trading 9.31% up in pre-market ahead of Q2 2026 earnings release
Eupraxia Pharmaceuticals is trading sharply higher at $7.40, up +9.31%, in pre-market on August 10, 2026, as investors may be positioning ahead of its Q2 2026...
Eupraxia Pharmaceuticals Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 11, 2026
For the second quarter of 2026, analysts expect Eupraxia Pharmaceuticals to report a consensus loss per share of $0.25 on zero revenue, with the current stock...
🔴 Eupraxia Pharmaceuticals is trading 11.4% down in pre-market with no confirmed catalyst identified
Eupraxia Pharmaceuticals is trading 11.4% down at $5.90 after no confirmed company-specific announcement, earnings release, or late-breaking catalyst was...
🟢 Eupraxia Pharmaceuticals is trading 12.6% up in after-hours trading — move remains unexplained
Eupraxia Pharmaceuticals is trading at $7.50 (+12.61%) in after-hours trading; the move remains unexplained. - No confirmed August 6, 2026 company-specific...
🔴 Eupraxia Pharmaceuticals is trading 10.5% down today in pre-market with no confirmed catalyst identified
Eupraxia Pharmaceuticals is trading 10.49% down at $5.80 in pre-market after no fresh company-specific announcement or overnight catalyst was identified for...
🟢 Eupraxia Pharmaceuticals is trading 8% up today on company-specific optimism and low after-hours liquidity
Eupraxia Pharmaceuticals is trading 8% up at $7.00 in after-hours trading, driven by company-specific optimism and low liquidity. • The stock continues the...
🟢 Eupraxia Pharmaceuticals Inc. is trading 7.06% up in pre-market
EPRX is trading at $6.98, up 7.06% in pre-market.
🔴 Eupraxia Pharmaceuticals is trading 5.3% down today in a pullback following yesterday's rebound
Eupraxia Pharmaceuticals is trading at $6.20 (-5.34%) following a significant 9.72% gain on July 30, with no new company-specific news, filings, or analyst...
🟢 Eupraxia Pharmaceuticals is trading 7% up today amid broader risk-on sentiment and dip-buying
Eupraxia Pharmaceuticals is trading 7% up today at $6.39 amid broader risk-on sentiment and dip-buying interest following a weak prior week. • The stock is...
🟢 Eupraxia Pharmaceuticals is trading 5.9% up today with no clear company-specific catalyst found
Eupraxia Pharmaceuticals is trading at $6.32 (+5.86%) in after-hours trading after closing the regular session at $5.97. • No company-specific announcements,...
🔴 Eupraxia Pharmaceuticals is trading 15.4% down today as it reverses yesterday's technical bounce
Eupraxia Pharmaceuticals is trading at $5.22, down 15.4%, as the stock appears to reverse gains from yesterday's technical bounce. • The decline follows a...
🟢 Eupraxia Pharmaceuticals is trading 5.2% up today on a technical bounce in a risk-on market
Eupraxia Pharmaceuticals is trading 5.2% up today at $6.11 on a technical bounce in a broadly risk-on market. • The stock is staging a recovery following a...
🟢 Eupraxia Pharmaceuticals is trading 6.5% up today as a technical bounce in a risk-on market
Eupraxia Pharmaceuticals is trading at $6.19 (6.5% up) in pre-market, staging a technical bounce following a sharp drop and reversal on July 24, 2026. • The...
🔴 Eupraxia Pharmaceuticals is trading 5.1% down today after reversing a sharp, unexplained pre-market rally
Eupraxia Pharmaceuticals is trading 5.1% down today at $5.98 as it gives back gains from a sharp, unexplained after-hours and pre-market rally. • The stock...
🟢 Eupraxia Pharmaceuticals is trading 15.9% up today with no clear catalyst identified
Eupraxia Pharmaceuticals is trading 15.9% up at $7.30 in pre-market trading, extending a sharp upward move that began during the July 23 after-hours...
🟢 Eupraxia Pharmaceuticals is trading 11.1% up today with no clear catalyst identified
Eupraxia Pharmaceuticals is trading 11.1% up at $7.00 in after-hours trading with no clear catalyst identified for the move. • The stock moved sharply higher...